文献速递药物不良反应与药物警戒

身份不明药物与老挝药物不良反应相关住院的横断面研究

Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic.
PubMed 文献 · Drug Saf · 2017-01-01

该研究在老挝首都万象一家中心医院前瞻性纳入2013年7周内453例成人非计划住院患者,通过视觉比对和质子核磁共振及质谱分析识别身份不明药物(MUI)。结果显示5.1%住院与ADR相关,使用MUI者因ADR住院风险显著升高(aOR 4.5,95%CI 1.7-11.5),MUI主要涉及出血性胃十二指肠溃疡。

要点

  • 使用MUI的患者因ADR住院的风险是使用已知身份药物者的4.5倍。
  • ADR相关住院频率为5.1%,MUI主要涉及出血性胃十二指肠溃疡。
  • 照片比对工具因外观相似药物存在误识别,需更适配的临床识别工具。

核心结论

  • 使用身份不明药物(MUI)与ADR相关住院风险升高独立相关(aOR 4.5,95%CI 1.7-11.5)。
  • 需确保发药时药品适当标注,并提供适用于临床的MUI识别工具以改善用药安全。

研究设计与样本

  • 2013年7周内在老挝万象首都一家中心医院前瞻性记录所有非计划住院(除外急性创伤和故意过量),纳入453例住院≥24小时的成人。
  • 通过访谈患者或亲属完成问卷,用视觉特征照片工具及质子核磁共振和质谱分析识别疑似涉事MUI,多因素logistic回归分析ADR相关因素。

主要发现

  • ADR相关住院频率为5.1%(23/453,95%CI 3.1-7.1)。
  • 使用MUI者因ADR住院的aOR为4.5(95%CI 1.7-11.5),高于使用已知身份药物者。
  • MUI主要涉及出血性胃十二指肠溃疡。
  • 照片工具因药物照片集中存在外观相似药品而导致误识别。

临床怎么用

  • 临床接诊近期使用过散装重新包装、无标识药品的患者时,应警惕ADR相关住院风险升高。
  • 发药环节应确保药品适当标注,减少身份不明药物的使用。
  • 临床机构需配备适合的MUI识别工具以辅助药物安全评估。

局限性

  • 研究为单中心横断面设计,为期7周,样本量453例。
  • 照片工具因外观相似药品存在误识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The health dangers of medicines of unknown identity (MUIs) [loose pharmaceutical units repackaged in individual bags without labelling of their identity] have been suspected in L/MICs. Using visual and analytical tools to identify MUIs, we investigated the frequency of, and factors associated with, adverse drug reaction (ADR)-related hospitalizations in a central hospital in Vientiane Capital, Lao People's Democratic Republic (PDR). METHODS: All unplanned admissions, except for acute trauma and intentional overdose, were prospectively recorded during a 7-week period in 2013, leading to include 453 adults hospitalized for ≥24 h. The patients or their relatives were interviewed to complete the study questionnaire. MUIs suspected of being involved in ADR(s) were identified through comparison of visual characteristics of tablets/capsules with that of reference medicines (photograph tool), and by proton nuclear magnetic resonance and mass spectrometry analyses. Factors associated with ADRs were identified by multivariate logistic regression. RESULTS: The frequency of hospitalizations related to an ADR was 5.1% (23/453, 95% confidence interval [CI] 3.1-7.1). Forty-eight (12.8%) patients used MUI(s) in the last 2 weeks preceding hospitalization. They were more likely to be hospitalized because of an ADR (adjusted odds ratio 4.5, 95% CI 1.7-11.5) than patients using medicines of known identity. MUIs were mainly involved in bleeding gastroduodenal ulcers. The photograph tool led to the misidentifications because of look-alike pharmaceutical units in the medicines photograph collection. CONCLUSION: According to the results of this study, there is a need to ensure appropriate labelling of medicines at dispensing and to provide well-suited tools to identify MUIs in clinical settings to improve drug safety and patients' care in developing countries with limited capacities for drug analysis.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Caillet C, Sichanh C, Assemat G, et al. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic. Drug Saf. 2017. PMID: 28528487. doi:10.1007/s40264-017-0544-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。